BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 34474708)

  • 21. Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach.
    Greenhawt M; Dribin TE; Abrams EM; Shaker M; Chu DK; Golden DBK; Akin C; Anagnostou A; ALMuhizi F; Alqurashi W; Arkwright P; Baldwin JL; Banerji A; Bégin P; Ben-Shoshan M; Bernstein J; Bingemann TA; Bindslev-Jensen C; Blumenthal K; Byrne A; Cahill J; Cameron S; Campbell D; Campbell R; Cavender M; Chan ES; Chinthrajah S; Comberiati P; Eastman JJ; Ellis AK; Fleischer DM; Fox A; Frischmeyer-Guerrerio PA; Gagnon R; Garvey LH; Grayson MH; Isabwe GAC; Hartog N; Hendron D; Horner CC; Hourihane JO; Iglesia E; Kan M; Kaplan B; Katelaris CH; Kim H; Kelso JM; Khan DA; Lang D; Ledford D; Levin M; Lieberman JA; Loh R; Mack DP; Mazer B; Mody K; Mosnaim G; Munblit D; Mustafa SS; Nanda A; Nathan R; Oppenheimer J; Otani IM; Park M; Pawankar R; Perrett KP; Peter J; Phillips EJ; Picard M; Pitlick M; Ramsey A; Rasmussen TH; Rathkopf MM; Reddy H; Robertson K; Rodriguez Del Rio P; Sample S; Sheshadri A; Sheik J; Sindher SB; Spergel JM; Stone CA; Stukus D; Tang MLK; Tracy JM; Turner PJ; Vander Leek TK; Wallace DV; Wang J; Wasserman S; Weldon D; Wolfson AR; Worm M; Yacoub MR
    J Allergy Clin Immunol; 2023 Aug; 152(2):309-325. PubMed ID: 37295474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series.
    Johnston MS; Galan A; Watsky KL; Little AJ
    JAMA Dermatol; 2021 Jun; 157(6):716-720. PubMed ID: 33978670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population-Based Incidence, Severity, and Risk Factors Associated with Treated Acute-Onset COVID-19 mRNA Vaccination-Associated Hypersensitivity Reactions.
    Macy E; Pandya S; Sheikh J; Burnette A; Shi JM; Chung J; Gin N; Crawford W; Zhang J
    J Allergy Clin Immunol Pract; 2022 Mar; 10(3):827-836. PubMed ID: 34971845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Allergy to Pfizer-BioNTech® vaccine demonstrated by skin testing].
    Estrada-García CD; Macías-Robles AP; Cortés-Grimaldo RM; Carvajal-Alonso HL; Barreto-Alcalá M; Ramírez-Nepomuceno A; Esparza-Amaya D; Coronado-Hernández KG; Barrios-Díaz B; Campos-Téllez HH
    Rev Alerg Mex; 2023 Jan; 69(2):89-92. PubMed ID: 36928249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staff with a history of allergy.
    Inoue S; Igarashi A; Morikane K; Hachiya O; Watanabe M; Kakehata S; Sato S; Ueno Y
    Respir Investig; 2022 Mar; 60(2):248-255. PubMed ID: 34920980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.
    Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N
    JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment and management of allergy history with a novel mRNA vaccine.
    Holt C; Butler J; Sharp K; McDonald J
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 35881510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute Allergic Reactions to mRNA COVID-19 Vaccines.
    Blumenthal KG; Robinson LB; Camargo CA; Shenoy ES; Banerji A; Landman AB; Wickner P
    JAMA; 2021 Apr; 325(15):1562-1565. PubMed ID: 33683290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
    Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anaphylaxis After the Covid-19 Vaccine in a Patient With Cholinergic Urticaria.
    Park HJ; Montgomery JR; Boggs NA
    Mil Med; 2022 Dec; 187(9):e1556-e1558. PubMed ID: 33851711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allergic reactions to COVID-19 vaccines: statement of the Belgian Society for Allergy and Clinical Immunology (BelSACI).
    Tuyls S; Van Der Brempt X; Faber M; Gadisseur R; Dezfoulian B; Schrijvers R; Froidure A;
    Acta Clin Belg; 2022 Jun; 77(3):552-557. PubMed ID: 33792500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Subjective well-being and ability to work of hospital staff after SARS-CoV2 immunization with the mRNA vaccine BNT162b2].
    Kalbhenn J; Hammer T; Hug M; Dürschmied D; Wenz F; Steinmann D
    Dtsch Med Wochenschr; 2021 Aug; 146(16):e58-e64. PubMed ID: 34243217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allergies and COVID-19 vaccines: An ENDA/EAACI Position paper.
    Barbaud A; Garvey LH; Arcolaci A; Brockow K; Mori F; Mayorga C; Bonadonna P; Atanaskovic-Markovic M; Moral L; Zanoni G; Pagani M; Soria A; Jošt M; Caubet JC; Carmo A; Mona AA; Alvarez-Perea A; Bavbek S; Benedetta B; Bilo MB; Blanca-López N; Bogas HG; Buonomo A; Calogiuri G; Carli G; Cernadas J; Cortellini G; Celik G; Demir S; Doña I; Dursun AB; Eberlein B; Faria E; Fernandes B; Garcez T; Garcia-Nunez I; Gawlik R; Gelincik A; Gomes E; Gooi JHC; Grosber M; Gülen T; Hacard F; Hoarau C; Janson C; Johnston SL; Joerg L; Kepil Özdemir S; Klimek L; Košnik M; Kowalski ML; Kuyucu S; Kvedariene V; Laguna JJ; Lombardo C; Marinho S; Merk H; Meucci E; Morisset M; Munoz-Cano R; Murzilli F; Nakonechna A; Popescu FD; Porebski G; Radice A; Regateiro FS; Röckmann H; Romano A; Sargur R; Sastre J; Scherer Hofmeier K; Sedláčková L; Sobotkova M; Terreehorst I; Treudler R; Walusiak-Skorupa J; Wedi B; Wöhrl S; Zidarn M; Zuberbier T; Agache I; Torres MJ
    Allergy; 2022 Aug; 77(8):2292-2312. PubMed ID: 35112371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CoronaVac/Sinovac COVID-19 Vaccine-Related Hypersensitivity Reactions and Second-Dose Vaccine Administration: Tertiary Allergy Center Experience.
    Gumusburun R; Dalgıc CT; Mete Gokmen EN; Sin AZ
    Int Arch Allergy Immunol; 2022; 183(7):778-784. PubMed ID: 35462361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions.
    Pitlick MM; Sitek AN; D'Netto ME; Dages KN; Chiarella SE; Gonzalez-Estrada A; Joshi AY; Park MA
    Ann Allergy Asthma Immunol; 2022 Feb; 128(2):153-160. PubMed ID: 34798275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allergic Reactions After the Administration of COVID-19 Vaccines.
    Bian S; Li L; Wang Z; Cui L; Xu Y; Guan K; Zhao B
    Front Public Health; 2022; 10():878081. PubMed ID: 35655467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Phenotypes of Immediate First-Dose Reactions to mRNA COVID-19: A Multicenter Latent Class Analysis.
    Stone CA; Robinson LB; Li L; Krantz MS; Kwah JH; Ortega G; Mancini C; Wolfson AR; Saff RR; Samarakoon U; Hong DI; Koo G; Chow TG; Gruchalla R; Liao JX; Kuster JK; Price C; Ahola C; Khan DA; Phillips EJ; Banerji A; Blumenthal KG
    J Allergy Clin Immunol Pract; 2023 Feb; 11(2):458-465.e1. PubMed ID: 36108922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result.
    Pitlick MM; Park MA; Gonzalez-Estrada A; Chiarella SE
    Ann Allergy Asthma Immunol; 2021 Oct; 127(4):498-499. PubMed ID: 34343674
    [No Abstract]   [Full Text] [Related]  

  • 40. Misdiagnosis of systemic allergic reactions to mRNA COVID-19 vaccines.
    Kelso JM
    Ann Allergy Asthma Immunol; 2021 Jul; 127(1):133-134. PubMed ID: 33781933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.